Belgium

ALS Center LEUVEN

The Leuven ALS center combines the diagnosis and multidisciplinary care for ALS and ALS/FTLD patients with clinical and basic research activities. Clinical research activities include genetic, imaging, electrophysiological and biomarker studies, as well as phase I-III clinical trials (P. Van Damme, MD, PhD). Basic research activities include generation of small animal models, rodent models and stem cell models for ALS and FTLD, and use them to identify and validate molecular targets for the treatment of these diseases (W. Robberecht MD, PhD, P. Van Damme, MD, PhD, and L. Van Den Bosch, PhD).

Details

Foundation year

1997

Director

Prof. dr. Philip Van Damme

Principal investigator(s)

Prof. dr. Philip Van Damme

Neurologists

Prof. dr. Philip Van Damme

Research nurses

Petra Tilkin
Ann D’Hondt
Dimphna Van Reijen
Goedele Couwelier
Annemie Devroye

Motto

The ultimate goal of the Leuven ALS center is to contribute to a novel treatment for ALS.

Team

Clinical trials

Type Name no patients
Investigator initiated

PYRAMID (Phenotype research for ALS Modifyer discovery)

15

Study of FDG-PET in ALS

170

Comparison of revised El Elscorial to Awaji-Shima algorithm for the diagnose of ALS

200

Publications

Have a look at our most recent publications

Contact information

ALS Center LEUVEN

Neurology Department, University Hospital Leuven,
Herestraat 49, 3000 Leuven, Belgium
Contact: Marielle Verbeek
+32 163 43508
Marielle.verbeek@uzleuven.be
http://www.uzleuven.be/amyotrofische-laterale-sclerose